Brighton Collaboration Releases New Template for Evaluating VSV-Based Lassa Fever Vaccines The Brighton Collaboration is proud to...

This April, global leaders in immunization, public health, and biotechnology convened in Washington, D.C. for the 2025 World Vacci...

Much has been learned about the need for vaccine safety surveillance through COVAX and other recent collaborative efforts. Here, w...

A member of both Brighton Collaboration and the Safety Platform for Emergency vACcines project’s Meta-DSMB, Dr. Punnee Pitis...

The proposed IDT Modified Vaccinia virus Ankara viral vector vaccine manuscript is ready for peer review. The Brighton Collaborati...

The proposed Clover COVID-19 recombinant protein vaccine manuscript is ready for peer review. The Brighton Collaboration BRAVATO (...

The World Health Organization (WHO) has reported a ten-fold increase in dengue cases over the past twenty years. Today, nearly 4 b...

The Task Force for Global Health welcomes Dr. Eileen Farnon as Brighton Collaboration’s new Research Director. Dr. Farnon, w...

The Vaccine Safety Working Group (VSWG) of COVAX was formed in November 2020 with representatives and consultants representing mul...

Vaccine safety data can help build public confidence in vaccines by communicating that the benefits outweigh the risks of immuniza...